Delivery Order SPE2DR25D2103-SPE2DR26F91VD
Award Date 12/29/25
Potential Completion Date 1/21/26
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $7,983.68 delivery order to AmerisourceBergen Drug Corp for 28 tablets of Imbruvica 280 mg on November 17, 2025, with completion scheduled for December 9, 2025. This firm fixed-price delivery order represents a non-competitive award issued under a larger indefinite delivery contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,983.68 for IMBRUVICA 280 MG tablets (28-count) under a firm fixed-price contract with an ultimate completion date of January 13, 2026. This competitively awarded, non-set-aside delivery order represents a continuation of the company's pharmaceutical supply services to federal military and healthcare systems. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,983.68 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count) on November 12, 2025, with completion targeted for December 4, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,967.36 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 mg tablets (28-count packaging) under a firm fixed-price contract. The award, made on November 17, 2025, with an ultimate completion date of December 9, 2025, represents a non-competitive delivery order issued against an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $7,983.68 to AmerisourceBergen Drug Corp for the supply of Imbruvica 280 mg tablets (28-count packages) with a firm fixed price contract type. This delivery order, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $47,902.08 delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count units) under a firm fixed-price contract. The award was made on December 15, 2025, with an ultimate completion date of January 7, 2026. This is a non-set-aside, competitively awarded contract supporting the federal government's pharmaceutical procurement needs. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $7,983.68 delivery order to AmerisourceBergen Drug Corp for 420 mg Imbruvica tablets (quantity: 28 units) on November 20, 2025, with completion scheduled for December 12, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Imbruvica 140 mg tablets (28-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 280 mg tablets (28-count) with a ceiling value of $15,967.36 under a firm fixed-price contract. The award, issued on December 16, 2025, is set to conclude by January 8, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded, non-set-aside delivery order that reflects the company's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count) with a ceiling value of $76,839.82. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...